Omeza Announces Board of Managers

Business

SRQ DAILY FRESHLY SQUEEZED CONTENT EVERY MORNING THURSDAY APR 25, 2019

Sarasota-based Omeza closed on its most recent funding round on March 28, exceeding its $5MM goal by $0.75MM and attracting its board members in the process. A medtech and consumer healthcare company, Omeza invited a select group of individuals to invest in its breakthrough technology, which is initially aimed at healing and preventing chronic leg and foot ulcers. Currently launching the second of its core OmezaTM omega oil products, the company will focus on evidence generation this quarter, as well as building out its marketing, sales and logistics capacity.

With the close of this round came the appointment of a Board of Managers. Omeza’s Board Chairman is Joel Morganroth, M.D., P.C., former CEO of (ERT) eResearch Technology Inc. Additional Board members are Ronald G. Gelbman, Executive Committee Member and Chairman of Pharmaceuticals and Diagnostics at Johnson & Johnson; Robert A. Essner, former Chairman and Chief Executive Officer of Wyeth; A.G. Lafley, former Chairman and CEO of Procter & Gamble; and Thomas Gardner, Omeza CEO and Founder.

Omeza

« View The Thursday Apr 25, 2019 SRQ Daily Edition
« Back To SRQ Daily Archive

Read More

Hospitality Stays Positive In Face of Pandemic Hit

Hospitality Stays Positive In Face of Pandemic Hit

Jacob Ogles | Jul 6, 2020

Grapevine Communications Gets A Refresh During Quarantine

Grapevine Communications Gets A Refresh During Quarantine

Jul 6, 2020

Selby Gardens Returns to Phase One of Reopening

Selby Gardens Returns to Phase One of Reopening

Jul 2, 2020

Blue Mimi Takes On Your To-Do List

Blue Mimi Takes On Your To-Do List

Ariel Chates | Jun 29, 2020